Sunshine Biopharma (SBFM) Inventory Average (2019 - 2026)

Sunshine Biopharma's Inventory Average history runs 8 years deep, the most recent figure standing at $13.3 million for Q1 2026.

• Quarterly Inventory Average rose 15.15% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 million (up 15.15% YoY) and the FY2025 annual result came in at $12.4 million, up 45.48% from the prior year.
• Inventory Average was $13.3 million for Q1 2026 at Sunshine Biopharma, down from $13.8 million in the prior quarter.
• Across five years, Inventory Average topped out at $13.8 million in Q4 2025 and bottomed at $143573.0 in Q1 2022.
• A 5-year average of $7.0 million and a median of $6.7 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average surged 2337.76% — and 2026, when it gained 15.15%.
• Sunshine Biopharma's Inventory Average stood at $1.8 million in 2022, then soared by 188.01% to $5.1 million in 2023, then surged by 105.81% to $10.5 million in 2024, then soared by 30.51% to $13.8 million in 2025, then dropped by 3.25% to $13.3 million in 2026.
• Business Quant data shows SBFM's Inventory Average at $13.3 million in Q1 2026, $13.8 million in Q4 2025, and $13.5 million in Q3 2025.